Get started
Author

Bing Yang

Observed institution: University of Wisconsin–Madison
ORCID: 0000-0001-8621-6838
Observed ORCID: 0000-0001-8621-6838
OpenAlex ID: A5138796232
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al. · Cancer Research · 2
Figure S6 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S3 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S6 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Data from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S2 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S2 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S7 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S3 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S4 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Figure S5 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Table S1 from MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer
2026 · Surendra Gulla, Tej Sharma, et al.
Works count: 15
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type